4
Changes in Ownership
Altimmune, Inc. Filed Acc 0001104659-25-006845
Chief Scientific Officer gave up 4,264 shares (to pay taxes)
- Chief Scientific Officer acquired 14,600 shares (option exercise)
From the SEC's structured data for this filing
Trades in this filing
Table I: Non-derivative
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Roberts M Scot Chief Scientific Officer | 2025-01-25 | Option exercise | +14,600 | 57,910 | D: show line 1 in the form | ||
| Roberts M Scot Chief Scientific Officer | 2025-01-25 | Shares withheld for taxes | −4,264 | $6.98 | $29,763 | 53,646 | D: show line 2 in the form |
Table II: Derivative
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Roberts M Scot Chief Scientific Officer | 2025-01-25 | Option exercise · Restricted Stock Units | +14,600 | 43,800 | D: show line 3 in the form | ||
| Roberts M Scot Chief Scientific Officer | 2025-01-27 | Grant or award · Stock Options (option to buy) | +183,600 | 183,600 | D: show line 4 in the form | ||
| Roberts M Scot Chief Scientific Officer | 2025-01-27 | Grant or award · Restricted Stock Units | +63,400 | 63,400 | D: show line 5 in the form |
Loading xslF345X05/tm254755-4_4seq1.xml…